These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27748583)

  • 1. Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2.
    Lauro ML; D'Ambrosio EA; Bahnson BJ; Grimes CL
    ACS Infect Dis; 2017 Apr; 3(4):264-270. PubMed ID: 27748583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP).
    Brahma B; Patra MC; Mishra P; De BC; Kumar S; Maharana J; Vats A; Ahlawat S; Datta TK; De S
    J Mol Graph Model; 2016 Apr; 65():15-26. PubMed ID: 26897084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide.
    Mann JK; Shen J; Park S
    J Cell Biochem; 2017 May; 118(5):1227-1238. PubMed ID: 27791288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into the MDP binding and CARD-CARD interaction in zebrafish (Danio rerio) NOD2: a molecular dynamics approach.
    Maharana J; Patra MC; De BC; Sahoo BR; Behera BK; De S; Pradhan SK
    J Mol Recognit; 2014 May; 27(5):260-75. PubMed ID: 24700593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
    Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA
    J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of MDP (muramyl dipeptide)-binding key domains in NOD2 (nucleotide-binding and oligomerization domain-2) receptor of Labeo rohita.
    Maharana J; Swain B; Sahoo BR; Dikhit MR; Basu M; Mahapatra AS; Jayasankar P; Samanta M
    Fish Physiol Biochem; 2013 Aug; 39(4):1007-23. PubMed ID: 23255217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannosylated adamantane-containing desmuramyl peptide recognition by the NOD2 receptor: a molecular dynamics study.
    Maršavelski A; Paurević M; Ribić R
    Org Biomol Chem; 2021 Aug; 19(32):7001-7012. PubMed ID: 34095941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
    Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
    Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the molecular differential recognition of muramyl peptide ligands by LRR domains of human NOD receptors.
    Vijayrajratnam S; Pushkaran AC; Balakrishnan A; Vasudevan AK; Biswas R; Mohan CG
    Biochem J; 2017 Jul; 474(16):2691-2711. PubMed ID: 28673961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freund's adjuvant, NOD2 and mycobacteria.
    Behr MA; Divangahi M
    Curr Opin Microbiol; 2015 Feb; 23():126-32. PubMed ID: 25483349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition.
    Lipinski S; Grabe N; Jacobs G; Billmann-Born S; Till A; Häsler R; Aden K; Paulsen M; Arlt A; Kraemer L; Hagemann N; Erdmann KS; Schreiber S; Rosenstiel P
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21426-31. PubMed ID: 23213202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the leucine-rich repeat domain of the NOD-like receptor NLRP1: implications for binding of muramyl dipeptide.
    Reubold TF; Hahne G; Wohlgemuth S; Eschenburg S
    FEBS Lett; 2014 Sep; 588(18):3327-32. PubMed ID: 25064844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
    Hedl M; Abraham C
    J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muramyl peptides activate innate immunity conjointly via YB1 and NOD2.
    Laman AG; Lathe R; Shepelyakovskaya AO; Gartseva A; Brovko FA; Guryanova S; Alekseeva L; Meshcheryakova EA; Ivanov VT
    Innate Immun; 2016 Nov; 22(8):666-673. PubMed ID: 27694635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
    Yao Q
    Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
    Inohara N; Ogura Y; Fontalba A; Gutierrez O; Pons F; Crespo J; Fukase K; Inamura S; Kusumoto S; Hashimoto M; Foster SJ; Moran AP; Fernandez-Luna JL; Nuñez G
    J Biol Chem; 2003 Feb; 278(8):5509-12. PubMed ID: 12514169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition.
    Tanabe T; Chamaillard M; Ogura Y; Zhu L; Qiu S; Masumoto J; Ghosh P; Moran A; Predergast MM; Tromp G; Williams CJ; Inohara N; Núñez G
    EMBO J; 2004 Apr; 23(7):1587-97. PubMed ID: 15044951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.
    Salem M; Seidelin JB; Rogler G; Nielsen OH
    Cell Mol Life Sci; 2013 Sep; 70(18):3391-404. PubMed ID: 23275943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship in NOD2 agonistic muramyl dipeptides.
    Kamboj A; Patil MT; Petrovsky N; Salunke DB
    Eur J Med Chem; 2024 May; 271():116439. PubMed ID: 38691886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.